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ABSTRACT 
Objective: Prevention of recurrent caries due to decreased oral clearance and an abnormal microbial milieu in patients suffering from xerostomia 
poses a significant challenge in restorative dentistry. The present study was designed to control Gram negative bacilli and S. aureus which comprise 
a majority of such atypical populations by using nanosilver modified dental composite.  
Methods: Silver nanoparticles were synthesised by the chemical reduction process using polyvinyl pyrrolidone as a stabilizer and ethylene glycol as 
the reducing agent. Nanoparticles were characterized using UV visible spectroscopy and a scanning electron microscope equipped with an energy 
dispersive X-ray analyser. Additionally a nanoparticle analyzer was used to determine the particle size and zeta potential of the nanosilver 
synthesized. The minimum inhibitory concentration of nanosilver for the test organisms was determined. Further, nanoparticle impregnated 
Anterior/ Posterior Nano-Hybrid composite was used to evaluate microbial biofilm inhibition. 
Results: The average size and charge of the nanoparticles were confirmed to be 80 nm and -10mV respectively. Atomic absorption spectroscopy 
revealed the concentration of the nanoparticles in solution to be 998.5 ppm. The minimum inhibitory concentration of nanosilver for E. coli and Ps. 
aeruginosa was found to be 0.49 ppm and 0.975 ppm respectively. A slightly higher concentration of 1.95 ppm nanosilver was required to inhibit S. 
aureus. The minimum bactericidal concentration/minimum inhibitory concentration ratio was ≤4 which indicated that nanoparticles displayed a 
predominant bactericidal activity against the test organisms. The Nano-Hybrid composite studies demonstrated a 102to105
Conclusion: To our knowledge, this is the first study to demonstrate the potential of silver nanoparticles, for controlling the formation of secondary 
dental caries due to pathogenic oropharyngeal colonization in patients suffering from xerostomia. 
 fold decrease in the 
viable count of bacteria as compared to the control.  
Keywords: Xerostomia, Nanosilver, Dental composite, Abnormal oral milieu, Biofilm.  
 
INTRODUCTION 
The term xerostomia is used to encompass a spectrum of oral 
complaints which become apparent when more than 50% reduction 
in salivary secretion occurs [1, 2]. Hyposecretion of saliva is most 
commonly seen as a manifestation of Sjogren’s syndrome, a chronic 
autoimmune disorder leading to the destruction of secretory acini of 
salivary glands [3]. Acute clinical symptoms of pain in the salivary 
glands, swelling and general dryness of the mouth have been 
reported to occur within minutes to several hours of radiation 
therapy. Additionally, xerostomia is also associated with other 
conditions such as HIV infection, vasculitis and bone marrow 
transplantation. Salivary hyposecretion is also observed commonly 
in a majority of the geriatric population. 
The decreased salivary production in xerostomia patients causes 
reduction in oral irrigation and an inability to clear foods rapidly 
from the buccal cavity. This leads to changes in the oral microbial 
milieu. Abnormalities in clearing allow colonization of the oral cavity 
by potentially pathogenic organisms such as E. coli, S. aureus, 
Pseudomonas, Klebsiella, Enterobacter and yeast [4]. Hence a major 
complication of xerostomia is the promotion of rapid dental caries 
and apthous ulcers. When salivary function is compromised there is 
an increase in the demineralization of the teeth, speeding the loss of 
tooth structure. Development of rampant caries has been observed 
within a few weeks after radiation therapy to the head and neck [5]. 
There is marked increase in the erosion and subsequent formation 
of dental caries, particularly observed on root surfaces and even 
cusp tips. In some patients, the decay becomes progressive even in 
the presence of vigilant oral hygiene.  
Formation of secondary dental caries after tending to primary ones, 
remain an unresolved problem in xerostomia patients [6]. New 
caries develop adjacent to or beneath the restorative filling of an old 
cavity. Microbes on the walls of the restorative filling can gain access 
to the cavity when microleakage occurs in the cementing material 
[7]. Ideally luting cements used as filling material, should possess 
bactericidal properties to limit adhesion and proliferation of 
pathogens at a very early stage [8]. Currently used glass ionomer 
endodontic cements are designed to release fluorides to suppress 
caries formation [9]. Numerous efforts have been made to improve 
the antimicrobial activity of dental restoratives with most of them 
focusing on slow releasing antibacterial agents such as zinc and 
silver ions [10]. Recently the use of nanosilver modified dental 
cements was explored for controlling S. mutans; an organism 
associated with tooth decay in otherwise healthy individuals 
[11,12,13]. The current study was designed to investigate whether a 
similar inhibition could be obtained against E. coli, Pseudomonas and 
S. aureus, selected as model organisms representing atypical 
pathogenic oropharyngeal colonization. This study could thus help 
to establish a method to prevent secondary dental caries, a major 
complication occuring in patients suffering from xerostomia.  
MATERIALS AND METHODS  
Culture and reagents 
Cultures of Pseudomonas aeruginosa, Escherichia coli and S. aureus 
were obtained from a local hospital. Microbial suspensions were 
obtained from a single colony isolated on agar plates and inoculated 
in nutrient broth (HiMedia) for overnight cultures. After incubating 
microbial cells at 370
The suspension was diluted with phosphate-buffered saline (pH 7.4) 
to 1:100 and suspended to the final concentration of 1.0 × 10
C overnight, optical density (OD) of the 
suspension at 600 nm was adjusted to 1.0 using a 
spectrophotometer (ErmaInc. Colorimeter).  
7 
cells/mL. Silver nitrate was purchased from SD Fine Chemical Ltd. 
Mumbai, while ethylene glycol and polyvinyl pyrrolidone were 
procured from Research Lab Fine Chemical Industries, India. 
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Preparation of silver nanoparticles 
13.5g of polyvinyl pyrrolidone (PVP) was dissolved in 75 ml of 
ethylene glycol (EG). 50 ml of this solution was transferred to 
another beaker to which 0.3g silver nitrate was added [14]. The 
mixture was agitated using a magnetic stirrer for 24 h at room 
temperature. Formation of a clear homogenous brown solution 
indicated the formation of the chemically synthesized silver 
nanoparticles (CAgNPs). 
Quantification and characterization of silver nanoparticles  
Characterization of the nanoparticles was done using UV visible 
spectroscopy (ELICO SL 207 MINI). For this 0.1 ml of test solution 
was diluted with 10 ml of ethylene glycol whereas 0.1 ml of PVP-EG 
diluted with 10 ml of ethylene glycol served as the blank solution. 
Quantification of the prepared silver nanoparticles was carried out 
by atomic absorption spectrophotometer (Perkin Elmer AA700) 
using air-acetylene flame [15]. Prior to analysis, the sample was 
digested using nitric acid on the hot plate for 3 hrs. The dry residue 
obtained was diluted with 5% nitric acid and filtered through 0.45µ 
filter. Further, the morphology of the CAgNPs was studied using 
Scanning electron microscope equipped with Energy Dispersive X 
ray Analyzer (Icon Analytical Pvt. Ltd). Each specimen was dispersed 
ultrasonically to separate individual particles before analysis. The 
zeta potential and the particle size distribution were confirmed with 
a nanoparticle analyzer (HORIBA SZ 100Z). 
Determination of minimum inhibitory concentration of CAgNPs 
against the test bacteria 
Using stock solution of the prepared silver nanoparticles, various 
dilutions were prepared. 0.1 ml of 24hr old test cultures E. coli, S. 
aureus and Pseudomonas aeruginosa were added to all dilutions. 
Positive and negative controls were maintained. Tubes were 
incubated at 370
Determination of minimum bactericidal concentration of 
CAgNPs against test bacteria 
C for 24 hrs and the lowest concentration that did 
not show growth corresponded to the minimum inhibitory 
concentration (MIC). 
0.1 ml of culture from the tubes indicating minimum inhibitory 
concentration and all higher concentrations beyond it were surface 
spread on nutrient agar and incubated at 370
Preparation of silver nanoparticle impregnated dental 
composites 
C for 24 hrs. The 
minimum bactericidal concentration (MBC) endpoint was the 
minimum concentration of CAgNPs at which at least 99.9% of the 
initial inoculum was eradicated and at which only one or no colonies 
could be seen on the agar.  
For the study Anterior/ Posterior Nano-Hybrid composite (ICE A2, 
SDI Ltd, Australia) was used. The composite was a restorative which 
was composed of 22.5% wt (39% volume) multifunctional 
methacrylic ester and 77.5% wt (61% volume) inorganic filler (40 
nm-1.5 micron). The ingredients of the composite material were 
removed from the syringe (1g at a time) on to the mixing pad. To this 
silver nanoparticle solution was added and the dough mixed 
together using a shaping tool to prepare small square blocks 1 cm x 
1 cm in size. To harden the composites they were photocured by a 
LED unit (Mako T-hand held wand) with a controlled wave length of 
450–470 nm for 60 seconds at one point. 
Susceptibility of biofilm to silver nanoparticles 
Blocks of dental composite impregnated with bactericidal 
concentrations of nanosilver (as determined previously) were 
placed in fresh nutrient broth with the test culture for 48 h. The 
incubation temperature was maintained at 370
Evaluation of biofilm 
C. Controls were 
maintained and consisted of blocks of dental composite without 
incorporating nanosilver. 
Each composite block was first dip-washed in sterile phosphate 
buffer saline (PBS) and gently swirled to remove any adherent 
medium. They were then placed in 2 ml PBS and the adherent cells 
harvested by scraping with the sterile scalpel. For determining the 
viable count, the homogenized cell suspension was serially diluted 
with PBS and 0.1 ml of the culture was surface spread on nutrient 
agar. Plates were incubated at 37 0
Experiments were performed in triplicate and repeated three times. 
Six blocks and eighteen plates of viable count were prepared for 
each set. The data was statistically analysed using student’s t-test. 
Values were considered significant when p value was less than 0.05.  
C for 24h and colonies counted.  
RESULTS 
Synthesis of silver nanoparticles was observed within 24 h and was 
indicated by the formation of a homogenous brown solution (Fig. 1).  
 
 
Fig. 1: Shows brown coloured chemically synthesized 
nanosilver solution. 
 
Particles exhibited maximum absorption at 420-440 nm on analysis 
with UV-visible spectroscopy corresponding to their surface 
plasmon resonance. The energy dispersive spectroscopic analysis of 
the nanoparticle dispersion confirmed the presence of elemental 
silver in the sample with trace amounts of oxygen (Fig. 2).  
 
 
Fig. 2: EDS spectra of CAgNPs with presence of silver and 
oxygen. 
 
Scanning electron micrograph revealed nanoparticles ranging in size 
from 60-80 nm. SEM studies showed presence of 
nanoparticles 
Further characterization using Nanoparticle Analyzer based on 
Dynamic Light Scattering (DLS) confirmed the size of the particles to 
be 80 nm.  
possessing two distinct morphologies, spherical and 
triangular, in solution (Fig. 3). 
Concentration of AgNPs in solution was found to be 998.5 ppm by 
atomic absorption spectroscopy. The mean surface charge of the 
synthesized CAgNPs was found to be -10mV. To examine the 
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bactericidal effect of CAgNPs, isolates of E. coli, S. aureus and 
Pseudomonas aeruginosa were analyzed under the same growth 
conditions, bacterial density, incubation time and temperature. 
There was no difference in the median MIC and MBC values obtained 
in three separate experiments conducted in triplicate. As shown in 
Table1 the concentration of nanosilver required to inhibit as well as 






Fig. 3: SEM images of CAgNPs possessing (a) spherical as well as 
(b) triangular morphologies. 
 
Table 1: MIC and MBC of CAgNPs for the test organisms in the 
planktonic state. 
Test organism MIC  MBC  
Escherichia coli 0.49 ppm 0.49 ppm 
S. aureus 1.95 ppm 1.95pm 
Pseudomonas aeruginosa 0.975 ppm 0.975 ppm 
It was noted that E. coli showed greater susceptibility to CAgNPs 
compared to other organisms. The amount of nanosilver to be 
incorporated in the dental composite was determined as per the 
MBC value obtained. Fig. 4 depicts the procedure of impregnating 
silver nanoparticles into the dental acrylic resin and the formation of 






Fig. 4: a) A shaping tool being used to make blocks of 1 cm x1 
cm. (b) Using a hand held curing unit, blue light was used to 
form hardened blocks. 
 
The ability of nanosilver to control atypical dental plaque microcosm 
growing in the form of a biofilm on the surface of dental composite 
was checked. The mean values of viable count are mentioned in 
Table 2. 
  
Table 2: Viable count of cells present within the biofilm formed on dental composite 
 Test organism 
 E. coli Ps. aeruginosa S. aureus 
Test (cfu/ml) 1.1x10 2.2x105 2.5x106 8 
Control (cfu/ml) 2.8x10[10] 3.2x10 4.1x10[10] 8 
 
The experimental data show that for all organisms tested, the 
CAgNP-containing composites exhibited a significant decrease in the 
number of viable cells within the biofilm as compared to the 
controls. It was evident that the addition of silver nanoparticles to 
the Anterior/ Posterior Nano-Hybrid composite rendered it with 
good antibacterial property effective against 
DISCUSSION 
the test organisms. 
The current study explores the use of nanosilver impregnated dental 
composite as a restorative material for the control of atypical oral 
microbial populations. These organisms are responsible for the 
increased tendency in patients suffering from xerostomia, to develop 
severe untreatable caries. Bactericidal property is an important 
feature to be considered while selecting a restorative material. 
Silver, known for its antimicrobial properties exerts its action by 
causing cell lysis or inhibition of cell transduction [16]. It has a far 
lower propensity to induce microbial resistance than antibiotics 
[17]. Compared to the original bulk material nanosilver possesses a 
higher surface area to volume ratio which provides an enhanced 
bactericidal effect. Silver nanoparticles can be made by both 
chemical and biological synthesis methods [18,19]. 
In the current study, silver nanoparticles were synthesized by the 
chemical reduction method involving polyvinyl pyrrolidone as a 
stabilizer and ethylene glycol as the reducing agent. The mean size of 
the prepared particles was 80 nm.  
In general, nanosilver have been observed to have the greatest 
antibacterial effect with the smallest particle sizes, with average 
diameters under 10 nm being most effective[11]. The hydrodynamic 
diameter of the nanoparticles measured by dynamic light scattering 
refers to how a particle diffuses within a fluid and is always greater 
than the size measured by electron microscopy. Previously it has 
been reported that nanosilver undergoes shape-dependent 
interaction with bacterial cells and that nanoparticles with the same 
surface area but with different shapes may also have different 
effective surface areas in terms of active facets [17]. Zeta potential 
a 
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analysis indicated stability and the interaction between particles and 
microbial cell surfaces. Typically, nanoparticles with zeta potentials 
greater than 20 mV or less than -20mV have sufficient electrostatic 
repulsion to remain stable in solution. While the mechanism of the 
interaction between these particles and the constituents of the outer 
membrane of bacterial cells also known to possess a negative 
surface charge, is unfortunately still unresolved, it would appear 
that, despite their negative surface charge, the nanoparticles 
somehow interacted with the “building elements” of the bacterial 
membrane, causing structural changes and degradation and finally, 
cell death. Previous researchers too have observed similar anomaly 
in the surface charge and interaction between nanoparticles and 
bacterial cells [16]. The MIC and MBC values were determined using 
broth microdilution assay with the end point at which 99.9% 
bacteria were inhibited or killed, respectively. The MBC/MIC ratio 
was ≤4 which indicated that the nanoparticles displayed a 
predominant bactericidal activity. 
Though the biofilm phenotype has been recognized only relatively 
recently in medical history, it is clear that the development of many, 
if not the majority of bacterial infections depends upon the 
formation of a biofilm. Ventilator associated pneumonia is a major 
complication occurring due to xerostomia and atypical dental 
biofilm formation in critical care patients [20]. The inhibitory action 
of nanosilver modified composite could mainly be
1. Guggeinheimer J, Moore PA. Xerostomia-etiology, recognition 
and treatment. J Am Dent Assoc 2003;134:61-9. 
 attributed to the 
release of silver ions from the composite upon its immersion in a 
liquid medium. Biofilms exhibit tolerance to biocides and 
chemotherapeutic agents and subsequently, biofilm-associated 
infections are extremely difficult to treat, making them a 
confounding clinical problem. It is known that all microbial cells 
within a biofilm express increased resistance and that the 
concentration of an antimicrobial compound required for 
eliminating them is considerably higher than that required for 
planktonic cells [21]. In our current study, though silver 
nanoparticles showed a significant decrease in the number of viable 
cells, complete inhibition of biofilm formation was not achieved. 
Hence it is suggested that further experiments may be devised 
employing composites with higher concentrations of nanoparticles. 
In conclusion, CAgNP-containing Anterior/ Posterior Nano-Hybrid 
composite displayed good antibacterial property. It could be used to 
inhibit biofilm production by organisms constituting an atypical oral 
milieu and prevent formation of secondary dental caries in 
xerostomia patients. However, further tests need to be performed to 
ensure that impregnation of nanosilver and increasing its 
concentration would not change the mechanical characteristics of 
the modified material and compromise its strength. Despite the 
effectiveness that silver nanoparticles have shown in dental practice, 
they remain a controversial area of research with respect to their 
toxicity in biological and ecological systems. Therefore any 
application of nanosilver in dentistry requires more study.  
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